1. Home
  2. CSAN vs AMRX Comparison

CSAN vs AMRX Comparison

Compare CSAN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSAN
  • AMRX
  • Stock Information
  • Founded
  • CSAN 1936
  • AMRX 2002
  • Country
  • CSAN Brazil
  • AMRX United States
  • Employees
  • CSAN N/A
  • AMRX N/A
  • Industry
  • CSAN Retail-Auto Dealers and Gas Stations
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSAN Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • CSAN Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • CSAN 2.6B
  • AMRX 2.4B
  • IPO Year
  • CSAN N/A
  • AMRX N/A
  • Fundamental
  • Price
  • CSAN $5.56
  • AMRX $7.41
  • Analyst Decision
  • CSAN Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • CSAN 1
  • AMRX 5
  • Target Price
  • CSAN $19.00
  • AMRX $10.80
  • AVG Volume (30 Days)
  • CSAN 1.3M
  • AMRX 2.1M
  • Earning Date
  • CSAN 05-27-2025
  • AMRX 05-02-2025
  • Dividend Yield
  • CSAN 6.26%
  • AMRX N/A
  • EPS Growth
  • CSAN N/A
  • AMRX N/A
  • EPS
  • CSAN N/A
  • AMRX N/A
  • Revenue
  • CSAN $7,106,136,253.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • CSAN $298.99
  • AMRX $10.49
  • Revenue Next Year
  • CSAN $3.48
  • AMRX $7.00
  • P/E Ratio
  • CSAN N/A
  • AMRX N/A
  • Revenue Growth
  • CSAN 11.36
  • AMRX 13.42
  • 52 Week Low
  • CSAN $4.31
  • AMRX $5.18
  • 52 Week High
  • CSAN $11.75
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • CSAN 56.40
  • AMRX 46.13
  • Support Level
  • CSAN $5.25
  • AMRX $7.15
  • Resistance Level
  • CSAN $5.82
  • AMRX $8.02
  • Average True Range (ATR)
  • CSAN 0.18
  • AMRX 0.32
  • MACD
  • CSAN 0.03
  • AMRX 0.02
  • Stochastic Oscillator
  • CSAN 73.74
  • AMRX 31.07

About CSAN Cosan S.A. ADS

Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: